会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • NOVEL INDAZOLE CARBOXAMIDES AND THEIR USE
    • 新型吲唑羧酰胺及其用途
    • WO2006002434A2
    • 2006-01-05
    • PCT/US2005/022870
    • 2005-06-24
    • SMITHKLINE BEECHAM CORPORATIONKERNS, Jeffrey, K.EDWARDS, Christine
    • KERNS, Jeffrey, K.EDWARDS, Christine
    • A61K31/454C07D403/02
    • C07D401/04C07D401/14C07D409/14
    • The invention is directed to novel indazole carboxamide derivatives. Specifically, the invention is directed to compounds according to Formula (I), wherein R1 and Z are defined below, and to pharmaceutically-acceptable salts thereof. The compounds of the invention are inhibitors of IKK2 and can be useful in the treatment of disorders associated with inappropriate IKK2 (also known as IKKß) activity, such as rheumatoid arthritis, asthma, and COPD (chronic obstructive pulmonary disease). Accordingly, the invention is further directed to pharmaceutical compositions comprising a compound of the invention. The invention is still further directed to methods of inhibiting IKK2 activity and treatment of disorders associated therewith using a compound of the invention or a pharmaceutical composition comprising a compound of the invention.
    • 本发明涉及新型吲唑甲酰胺衍生物。 具体而言,本发明涉及式(I)的化合物及其药学上可接受的盐,其中R 1和Z如下定义。 本发明的化合物是IKK2的抑制剂,并且可用于治疗与不适当的IKK2(也称为IKKß)活性相关的病症,例如类风湿性关节炎,哮喘和COPD(慢性阻塞性肺病)。 因此,本发明还涉及包含本发明化合物的药物组合物。 本发明还涉及使用本发明化合物或包含本发明化合物的药物组合物抑制IKK2活性和治疗与之相关的病症的方法。